Cavalie Fanny, Chief Strategy/Bus Ops Officer at Foghorn Therapeutics, holds 75.99K shares in Foghorn Therapeutics (Ticker: FHTX). Most recently, Cavalie Fanny Sold $11,000 shares of Foghorn Therapeutics on Mar 12, 2024 for an estimated value of 72.05K.